CIPRANDI, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 2.612
AS - Asia 1.513
EU - Europa 1.010
SA - Sud America 253
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 51
OC - Oceania 3
Totale 5.526
Nazione #
US - Stati Uniti d'America 2.545
CN - Cina 466
SG - Singapore 456
IE - Irlanda 318
HK - Hong Kong 208
BR - Brasile 198
RU - Federazione Russa 159
VN - Vietnam 157
DE - Germania 130
FI - Finlandia 96
FR - Francia 75
IN - India 61
IT - Italia 58
BD - Bangladesh 50
GB - Regno Unito 40
SE - Svezia 38
CA - Canada 31
ZA - Sudafrica 22
AR - Argentina 18
MX - Messico 18
IQ - Iraq 17
JP - Giappone 17
PL - Polonia 16
PK - Pakistan 14
ID - Indonesia 12
NL - Olanda 12
CO - Colombia 10
ES - Italia 10
UA - Ucraina 10
AT - Austria 9
EC - Ecuador 9
EG - Egitto 8
VE - Venezuela 8
KE - Kenya 7
TR - Turchia 7
SA - Arabia Saudita 6
BE - Belgio 5
CL - Cile 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
LT - Lituania 5
PH - Filippine 5
RS - Serbia 5
UZ - Uzbekistan 5
MA - Marocco 4
IL - Israele 3
KR - Corea 3
LA - Repubblica Popolare Democratica del Laos 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
LU - Lussemburgo 1
LV - Lettonia 1
MF - Saint Martin 1
MN - Mongolia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 5.445
Città #
Ashburn 322
Dublin 318
San Jose 287
Chandler 271
Singapore 249
Dallas 248
Hong Kong 207
Beijing 124
Boardman 70
Council Bluffs 66
Princeton 66
Helsinki 62
Lauterbourg 60
Lawrence 60
Los Angeles 58
Munich 54
Medford 53
Nanjing 42
New York 41
Wilmington 40
Ho Chi Minh City 38
Shanghai 35
Santa Clara 34
Redondo Beach 32
Turku 30
Dong Ket 28
Hanoi 28
Ann Arbor 24
Buffalo 24
Nanchang 22
São Paulo 22
Dearborn 21
Changsha 20
Johannesburg 20
Washington 20
Moscow 18
The Dalles 17
Tokyo 17
Hebei 16
Seattle 16
Hangzhou 15
Da Nang 14
Jacksonville 14
Atlanta 13
Warsaw 13
Frankfurt am Main 12
Orem 12
Redwood City 12
San Francisco 12
Tianjin 12
London 11
Phoenix 11
Shenyang 11
Boston 10
Brooklyn 9
Nuremberg 9
Toronto 9
Brasília 8
Chicago 8
Columbus 8
Milan 8
Pune 8
Chennai 7
Montreal 7
Rio de Janeiro 7
Stockholm 7
Amsterdam 6
Baghdad 6
Fairfield 6
Lyon 6
Mexico City 6
Brussels 5
Cambridge 5
Charlotte 5
Delhi 5
Denver 5
Hefei 5
Houston 5
Norwalk 5
Poplar 5
Porto Alegre 5
Thái Nguyên 5
Berlin 4
Bắc Ninh 4
Cairo 4
Falkenstein 4
Haiphong 4
Jakarta 4
Kunming 4
Lahore 4
Las Vegas 4
Manchester 4
Nairobi 4
Woodbridge 4
Belgrade 3
Campinas 3
Chandigarh 3
City of London 3
Contagem 3
Faisalabad 3
Totale 3.598
Nome #
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of invasive pulmonary aspergillosis: a prospective cohort study 189
A polycentric, randomized, double blind, parallel-group, placebo-controlled study on Lertal®, a multicomponent nutraceutical, as add-on treatment in children with allergic rhinoconjunctivitis: phase I during active treatment 153
Allergen-specific immunoglobulin E and allergic rhinitis severity 144
Antihistamines in children and adolescents: A practical update 141
Adenoids and clinical symptoms: Epidemiology of a cohort of 795 pediatric patients 138
Cross reactivity between recombinant parvalbumin of carp and cod and recombinant grass molecules 133
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II 132
Asthma endotyping and biomarkers in childhood asthma 127
Phleum pratense molecular pattern across Italy 118
Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares 115
Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis 114
Low-dose multicomponent medication modulates humoral and cellular immune response in an ex-vivo study on children subjected to adenoid surgery 113
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of Invasive Pulmonary Aspergillosis: a prospective cohort study 112
Allergen immunotherapy in children and adolescents with respiratory diseases 110
Biologic Use in Allergic and Asthmatic Children and Adolescents during the COVID-19 Pandemic 110
Allergen-specific immunoglobulin E and allergic rhinitis severity 109
Allergen Immunotherapy in Pediatric Asthma: A Pragmatic Point of View 103
Anxiety and Depression in Adolescents with Severe Asthma and in Their Parents: Preliminary Results after 1 Year of Treatment 101
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic 98
COVID-19 in the pediatric population admitted to a tertiary referral hospital in Northern Italy: Preliminary clinical data 98
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma 95
Anxiety/depression changes are associated with improved asthma control perception in asthmatic adolescents after adequate management 94
Severe asthma in children: Current goals and unmet needs 94
Biomarkers of immunotherapy response in patients with allergic rhinitis 91
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents 91
Asthma control in children and adolescents: a study in clinical practice 89
Cough Remedies for Children and Adolescents: Current and Future Perspectives 87
Allergy and Otitis Media in Clinical Practice 82
Pentraxin 3 and D-dimer in children with asthma: A real-world study 80
Allergen immunotherapy and asthma 80
Attitude to food supplement use: a survey promoted by the Italian Society of Pediatric Allergy and Immunology 77
Asthma in children and adolescents: The control’asma project 77
Immunotherapy and asthma in children 76
Anxiety and depression in adolescents with asthma and in their parents: A study in clinical practice 76
Special Issues for Coronavirus Disease 2019 in Children and Adolescents 76
Personalized therapies for the treatment of allergic rhinitis 72
Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children 71
The psycho-social effects of COVID-19 on Italian adolescents' attitudes and behaviors 69
Pragmatic Markers in the Management of Asthma: A Real-World-Based Approach 68
Profiles of birch sensitization (Bet v 1, Bet v 2, and Bet v 4) and oral allergy syndrome across Italy 65
Allergic rhinoconjunctivitis: Pathophysiological mechanism and new therapeutic approach 65
The relevance of symptom perception in the management of severe asthma in adolescents 65
Foreword 64
Focus on the cetirizine use in clinical practice: a reappraisal 30  years later 63
Complementary treatment of allergic rhinoconjunctivitis: The role of the nutraceutical lertal® 63
New approaches for identifying and testing potential new anti-asthma agents 60
Tryptophan metabolic pathway and neopterin in asthmatic children in clinical practice 60
What are the effects of rhinitis on patients with asthma? 60
Can an otorhinolaryngological visit induce the suspect of allergic rhinitis in children? 60
Resveratrol: immunological activity and possible application in children and adolescents with allergic rhinitis 59
The treatment of allergic rhinitis in asthmatic children and adolescents: practical outcomes from the real-world "ControL'Asma" study 58
The practical clinical relevance of rhinitis classification in children with asthma: outcomes of the “ControL'Asma” study 57
Exploring the Role of Lactoferrin in Managing Allergic Airway Diseases among Children: Unrevealing a Potential Breakthrough 56
The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy 55
Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019 55
The Measurement of Asthma and Allergic Rhinitis Control in Children and Adolescents 54
Lertal®, a multicomponent nutraceutical, could reduce the use of antihistamines in children with allergic rhinoconjunctivitis 54
Vitamin D3 in children with allergic asthma in clinical practice 49
The relevance of symptom perception in the management of severe asthma in adolescents 49
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019 48
COVID-19 in Italy: The Point of View of the Italian Society of Pediatric Allergy and Immunology-COVID-19 Commission 48
Cetirizine use in childhood: An update of a friendly 30-year drug 45
Respiratory infections in allergic children: The preventive role of a multicomponent nutraceutical 42
To prevent the allergic disease: The dream of the allergist 42
Letters to the Editor 42
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 41
Thermal water inhalation for allergic rhinitis and recurrent respiratory infections: a narrative review of the evidence 34
Ketoprofen lysine salt for relieving acute pain: a multi-regression analysis 4
Azelastine‐fluticasone intranasal therapy: A paradigm shift in pediatric allergic rhinitis management. A point of view of the Italian Society of Pediatric Allergy and Immunology 4
Multidisciplinary Delphi Consensus on management of children with moderate-severe atopic dermatitis 2
Totale 5.526
Categoria #
all - tutte 26.753
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.753


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022281 0 2 12 6 10 18 5 17 11 11 41 148
2022/2023819 97 49 6 73 52 85 0 39 376 8 27 7
2023/2024410 44 58 38 38 35 105 20 30 2 25 5 10
2024/20251.017 18 74 30 52 22 52 67 43 242 29 143 245
2025/20262.338 189 158 293 194 288 119 492 90 193 131 96 95
2026/2027238 158 80 0 0 0 0 0 0 0 0 0 0
Totale 5.526